During the COVID-19 pandemic, vaccine mandates were controversial, but they still successfully increased vaccination rates. A new study of South Texas residents by researchers at Rice University and University of Texas Health ...
Jun 18, 2024
0
1
Every year, medical diagnostics get better and better thanks to the tremendous development of new methods that enable the precise detection of the many different molecules present in biological fluids during an infection. ...
May 29, 2024
0
0
Sepsis patients could be treated based on their immune system's response to infection, not their symptoms.
Jun 18, 2024
0
8
A shift in testing for and managing gestational diabetes mellitus (GDM) to much earlier in pregnancy (before 14 weeks) can prevent health complications for both the mother and baby, according to a new series published in ...
Jun 20, 2024
1
42
What causes food allergies to develop? There's compelling evidence that suggests imbalances of the gut microbiome could be to blame, creating inflammation of the intestinal tract and a gut environment that's prone to food ...
Jun 21, 2024
0
4
Researchers from the University of Adelaide could be closer to discovering a better way to use metformin, a common type 2 diabetes medication.
Jun 7, 2024
0
4
A recent collaborative research endeavor, published in Cell Reports Medicine, highlights a promising therapeutic avenue for amyotrophic lateral sclerosis (ALS). Led by researchers from Ben-Gurion University of the Negev in ...
May 29, 2024
0
12
Two types of endometriosis-related ovarian cancer arise from the same cells but likely at different stages of the menstrual cycle—a nuance that significantly influences treatment response, reports a recent study led by ...
May 28, 2024
0
36
Although diet is the leading contributor to premature death from heart disease in the United States, fewer than one-quarter of people who undergo major heart events receive dietary counseling in the aftermath, a study finds.
Jun 3, 2024
0
1
Treating prostate cancer with immunotherapy is currently difficult to do. But results from a first in-human Phase I trial using a chimeric antigen receptor (CAR) T cell therapy developed by researchers from City of Hope, ...
Jun 12, 2024
0
1
